These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1716412)
1. Ki-67 staining as a means to simplify analysis of tumor cell proliferation. Hitchcock CL Am J Clin Pathol; 1991 Oct; 96(4):444-6. PubMed ID: 1716412 [No Abstract] [Full Text] [Related]
2. Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations. Sahin AA; Ro JY; el-Naggar AK; Wilson PL; Teague K; Blick M; Ayala AG Am J Clin Pathol; 1991 Oct; 96(4):512-9. PubMed ID: 1716414 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody Ki-67. Wong FW Gynecol Obstet Invest; 1994; 37(2):123-6. PubMed ID: 8150368 [TBL] [Abstract][Full Text] [Related]
4. [A simple method for flow cytometric measurement of Ki-67 reactive antigen on small solid tissues]. Murakami T; Oga A; Uchiyama T; Kimura Y; Morimoto H; Suzuki T; Takahashi M Gan To Kagaku Ryoho; 1993 Apr; 20(6):737-40. PubMed ID: 7683864 [TBL] [Abstract][Full Text] [Related]
5. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen. Yu CC; Dublin EA; Camplejohn RS; Levison DA Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317 [TBL] [Abstract][Full Text] [Related]
7. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113 [TBL] [Abstract][Full Text] [Related]
10. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Yu CC; Filipe MI Histochem J; 1993 Dec; 25(12):843-53. PubMed ID: 7906685 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies. Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766 [TBL] [Abstract][Full Text] [Related]
12. Which proliferation markers for routine immunohistology? A comparison of five antibodies. Rose DS; Maddox PH; Brown DC J Clin Pathol; 1994 Nov; 47(11):1010-4. PubMed ID: 7829674 [TBL] [Abstract][Full Text] [Related]
13. [Expression of a proliferation associated-nuclear antigen defined by Ki-67 monoclonal antibody in childhood acute leukemia]. Ito M; Tsurusawa M; Kawai S; Fujimoto T Rinsho Ketsueki; 1995 Aug; 36(8):713-9. PubMed ID: 7563603 [TBL] [Abstract][Full Text] [Related]
14. Effect of embolisation of meningioma on Ki-67 proliferation index. Paulus W; Meixensberger J; Hofmann E; Roggendorf W J Clin Pathol; 1993 Sep; 46(9):876-7. PubMed ID: 8227445 [TBL] [Abstract][Full Text] [Related]
15. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis. Traganos F; Gong J; Ardelt B; Darzynkiewicz Z J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of proliferative cells. Mokrý J; Nĕmecek S Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626 [TBL] [Abstract][Full Text] [Related]
17. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions. Thiele J; Bertsch HP; Kracht LW; Anwander T; Zimmer JD; Kreipe H; Fischer R J Pathol; 1994 May; 173(1):5-12. PubMed ID: 7523642 [TBL] [Abstract][Full Text] [Related]
18. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150 [TBL] [Abstract][Full Text] [Related]
19. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry. Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786 [TBL] [Abstract][Full Text] [Related]
20. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Gerdes J Semin Cancer Biol; 1990 Jun; 1(3):199-206. PubMed ID: 2103495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]